Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol., 29 February 2024
Sec. Bone Research

Comparison of diagnostic efficacy between 99mTc-methylene diphosphate SPECT/CT and MRI for bone and joint infections: a multicenter retrospective analysis

Hao Gao&#x;Hao Gao1†Guoquan Li&#x;Guoquan Li2†Congxiao Fu&#x;Congxiao Fu1†Jun RenJun Ren1Fei KangFei Kang2Wen LuoWen Luo3Qian YinQian Yin4Cheng ZhouCheng Zhou2Bo LiBo Li4Shuaikun LuShuaikun Lu1Hu WangHu Wang1Yong Zhang*Yong Zhang1*Yunfei Zhang*Yunfei Zhang1*
  • 1Department of Orthopaedics, Second Affiliated Hospital, Air Force Medical University, Xi’an, Shaanxi, China
  • 2Department of Nuclear Medicine, First Affiliated Hospital, Air Force Medical University, Xi’an, Shaanxi, China
  • 3Department of Ultrasound, First Affiliated Hospital, Air Force Medical University, Xi’an, Shaanxi, China
  • 4Department of Radiology, Second Affiliated Hospital, Air Force Medical University, Xi’an, Shaanxi, China

Objective: There is currently no non-invasive examination that can fully determine the diagnosis of osteomyelitis. SPECT/CT tomographic fusion imaging can provide both local metabolic activity and anatomical information to determine the condition and location. This study evaluates the diagnostic efficacy of 99mTc-MDP SPECT/CT in bone infections, compared to MRI.

Methods: In this multicenter retrospective study, 363 patients with suspected bone and joint infections or osteomyelitis were included. Participants underwent 99mTc-MDP SPECT/CT and/or MRI examinations, supplemented by pathogenic bacterial cultures and histopathological analysis.

Results: Only SPECT/CT was tested in 169 patients, and only MRI was used in 116. 78 people have implemented both inspections and have detailed information. The diagnostic sensitivity and specificity of SPECT/CT for infection were 96% and 92% respectively, with an accuracy of 96%. For MRI, these figures were 88%, 84%, and 87% respectively.

Conclusion: This represents the largest global study to date evaluating osteomyelitis and bone infection diagnosis using 99mTc-MDP SPECT/CT tomographic fusion imaging. The findings indicate that 99mTc-MDP SPECT/CT fusion imaging offers superior diagnostic accuracy compared to MRI. This is particularly evident in cases involving metallic implants and chronic infections. 99mTc-MDP SPECT/CT fusion imaging emerges as a highly suitable non-invasive diagnostic modality, facilitating enhanced clinical follow-up and treatment.

Introduction

Osteomyelitis and bone infections present significant challenges in contemporary orthopedic practice. In Europe, there has been a 10.44% increase in osteomyelitis incidence over recent years (1). In Asia, the rate ranges from 7.8 to 9.1 cases per 100,000 people annually (2). Patients may experience local discomfort, lack of mobility, severe complications, and substantial financial burden.

At present, there is no completely clear diagnosis to identify bone infection (3). Surgeons often depend on a comprehensive assessment encompassing clinical symptoms, laboratory investigations, bacterial cultures, and imaging findings, yet each of these methods has inherent limitations. The development of an early and precise diagnostic tool is of paramount importance.

SPECT/CT is capable of identifying musculoskeletal infections. It is particularly suitable for patients with multiple site infections and metallic implants (4). 99mTc-MDP (99mTc labeled methylene diphosphate) bone scintigraphy reveals radioactive uptake in areas of abnormal blood flow, altered bone salt metabolism, and osteogenesis associated with local bone lesions (5). PET also yields metabolic activity data, but it is not a specific bone imaging agent and is not suitable for assessing bone metabolism. Most notably, SPECT/CT stands out as a more cost-effective option (6). Therefore, SPECT/CT seems particularly valuable for delineating lesions and their associated inflammatory or infectious activities.

In recent years, there has been a surge in research exploring the role of nuclear medicine in osteomyelitis. However, these studies often suffer from small sample sizes and there is a lack of comparative studies with routine examination and corresponding subgroups. Especially after the widespread use of SPECT/CT fusion imaging technology. Consequently, we utilized the advantage of our existing large sample size to study the diagnostic efficacy of 99mTc-MDP SPECT/CT for bone infection diseases and compared it with conventional MRI methods. Additionally, we examined the influence of variables such as the presence of metallic implants.

Patients and methods

This study is a multicenter retrospective study. Patients suspected of bone and joint infections or osteomyelitis admitted to the orthopedics department of two affiliated hospitals of the Medical University from January 2017 to June 2023 were included. Doctors suspect that the patient’s osteomyelitis or bone infection is due to clinical signs and abnormal laboratory test results (3). They underwent 99mTc-MDP SPECT/CT and/or MRI examination, along with additional diagnostic procedures (Figure 1). The study protocol was approved by the Medical University’s Ethics Committee (K202309-12). Exclusion criteria included:

I: Patients with missing clinical data and incomplete medical records;

II: Patients who refuse to participate in the study;

III: Patients with other bone destruction diseases;

IV: Patients with specific bone infections such as tuberculosis.

Figure 1
www.frontiersin.org

Figure 1 Diagnostic analysis flowchart for 363 patients.

Diagnosis of osteomyelitis or bone infection is based on preoperative or intraoperative microorganism cultivation and tissue pathology with clear evidence. Microbial cultures are conducted in the presence of bacteria or based on inflammatory signs in tissue samples (7). The determination of whether a patient carries a metal implant is based on visual imaging data. The determination of the acute and chronic stages of a patient’s onset is based on the onset time, with the first 8 weeks being the acute stage and over 8 weeks being the chronic stage (8).

Nuclear medicine imaging

Adults received 20 to 25mCi of 99mTc MDP intravenously. The dose for children was calculated as 250μCi/Kg. After 3-4 hours, the patient is placed in a supine position and a full body anteroposterior bone imaging is taken. SPECT/CT tomography is performed by collecting SPECT and CT images centered around the lesion and performing simultaneous fusion. The imaging instrument is SIEMENS SYMBIA T2 True Point SPECT/CT, and the SPECT/CT fusion image is processed using Syngo software.

Magnetic resonance imaging

Using SIEMENS AG, German MAGNETOM Verio 1.5T for imaging, multiple sequences were executed. Routine cross-sectional and coronal T1WI and T2WI scans, with some additional sagittal scans. The area of interest was aligned with the coil center for optimal imaging. Routine coronal and cross-sectional T1WI and T2 STIR images of the hip and shoulder joints should be taken, and attention should be paid to symmetry on both sides during imaging. If necessary, sagittal scans should be added. Take routine T1WI and T2 STIR coronal and cross-sectional imaging of the knee joint, upper arm, and lower leg, and add sagittal scanning if necessary.

Image analysis

Image analysis of SPECT/CT and MRI was performed independently by two experienced nuclear medicine physicians and two radiologists in a blinded manner. In case of inconsistent diagnosis, the results of comprehensive discussion shall prevail.

Statistical analysis

The sensitivity, specificity, predictive value, likelihood ratio, diagnostic ratio, diagnostic accuracy, and Kappa value of SPECT/CT, MRI, and the combination of the two were calculated according to the previously mentioned reference standards. The statistical analysis software was SPSS version 26.0 (SPSS, Chicago, IL, USA), and the measurements were expressed as 95% confidence intervals, and statistically analyzed using the paired chi-square test. p<0.05 was considered statistically significant.

Results

Patient’s characteristics

A total of 169 suspected patients who only underwent 99mTc-MDP SPECT/CT and 116 suspected patients who only underwent MRI are included. In addition, 78 patients had both examinations, providing comprehensive data (Table 1). The majority of cases were male (77.3%, 72.2%, and 73.1% in each group, respectively). There is no significant difference among the three groups. The age distribution was also relatively uniform, which was 43.30, 41.04, and 42.53 years old, respectively, and there is no difference among the three groups. There were 101 patients with implants in SPECT/CT, 19 patients with implants in MRI, and 12 patients with implants in both imaging modalities, and there is no significant difference among the three modalities. Diagnosis in all patients was confirmed through at least one of the two methods: clinical pathogen testing or histopathological examination. The proportion of patients who underwent pathogenic bacteria detection or pathological detection was the highest (96.7%), followed by SPECT/CT (92.0%) and MRI (90.0%). For patients diagnosed with osteomyelitis, the disease types were also analyzed. Hematogenous osteomyelitis accounted for a high proportion of MRI, with 101 cases. More patients with SPECT/CT had a history of trauma (148 cases). The number of cases of hematogenous osteomyelitis and traumatic osteomyelitis were 29 and 39, respectively.

Table 1
www.frontiersin.org

Table 1 Main demographic characteristics of 363 patients.

Comparison of diagnostic efficacy between 99mTc-MDP SPECT/CT and MRI

In this study, a total of 247 people underwent 99mTc-MDP SPECT/CT testing. This included 101 cases in the endoprosthesis group and 146 cases without endoprostheses. Correspondingly, in MRI, it is 19 and 175, respectively (Table 2). Except for MRI containing metallic implants, the P-values of statistical tests for all other categories were less than 0.01, indicating significant differences. In reality, only 19 patients with local defects containing implants underwent MRI imaging, a sample size too small for reliable statistical analysis.

Table 2
www.frontiersin.org

Table 2 Diagnostic efficacy of 99mTc-MDP SPECT/CT and MRI individually.

Compared to the high sensitivity and specificity of SPECT/CT, MRI results were only 88% and 84%. Additionally, the diagnostic accuracy, negative predictive value (NPV), and likelihood ratio for MRI were also lower than those for SPECT/CT. Notably, MRI generally underperformed in consistency testing compared to the gold standard. In contrast, SPECT/CT showed excellent concordance with resultant values >0.75.

SPECT/CT’s superior diagnostic performance was consistent irrespective of the presence or absence of metal endoprostheses. Specifically, in the presence of metallic implants, the diagnostic accuracy, positive likelihood ratio, negative likelihood ratio, and Kappa value were 94%, 8.51, 0.06, and 0.695, respectively, although the sensitivity and specificity were similar to those of MRI. In cases without endoprostheses, the diagnostic efficacy of SPECT/CT was even more pronounced. This indicates that SPECT/CT has excellent and reliable diagnostic ability for bone and joint infections, especially in the presence of metal implants.

Additionally, our team performed an analysis of the diagnostic efficacy in both acute and chronic onset scenarios (Table 3). The results showed that there was no significant difference in diagnostic sensitivity and specificity between SPECT/CT and MRI, and the former remained superior. In the acute phase, the Kappa value of SPECT/CT and the gold standard was 0.897, which is better than 0.601 and 0.530 of MRI in the acute phase and chronic phase, respectively. In addition, in terms of predicted values and likelihood ratios, there are no significant differences between the two tests in both subgroups. It is particularly pointed out that in the chronic stage of the disease, with the presence of metal implants, the positive likelihood ratio of SPECT/CT is as high as 11.77, indicating a high diagnostic value.

Table 3
www.frontiersin.org

Table 3 Diagnostic efficacy of 99mTc-MDP SPECT/CT and MRI individually in the chronic phase of illness.

Diagnostic efficacy of combined use of 99mTc-MDP SPECT/CT and MRI

We also analyzed the diagnostic efficacy of the combination of MRI and SPECT/CT. A cohort of 78 patients who underwent both MRI and SPECT/CT during the same period and for whom complete data were available was analyzed. The relevant data were obtained by the calculation principle of the tandem combination test (Table 4). The specific implementation method of the series combination test is based on the positive MRI findings. If the SPECT/CT results are positive, the combined detection will yield a positive outcome; conversely, if the SPECT/CT results are negative, the combined detection will yield a negative outcome. The combined use resulted in overall specificity, sensitivity, and diagnostic accuracy superior to MRI alone and comparable to SPECT/CT alone (98%, 100%, and 98%, respectively). Similarly, we analyzed the case of the endophyte. Without implants, the diagnostic sensitivity, specificity, and accuracy of MRI and SPECT/CT were generally consistent and close to the parametric results of SPECT/CT alone and significantly better than MRI alone. It was evident in this group that the negative likelihood ratio of MRI alone was as high as 0.34 and the Kappa value as low as 0.242. The results of the comparison between the acute and chronic conditions are presented in Table 5, and the results are consistent with the above. When combined, it has a higher diagnostic ability than MRI in the acute and chronic phases of the disease and is better than the whole.

Table 4
www.frontiersin.org

Table 4 Diagnostic efficacy of combined use of 99mTc-MDP SPECT/CT and MRI.

Table 5
www.frontiersin.org

Table 5 Diagnostic efficacy of combined use of 99mTc-MDP SPECT/CT and MRI in acute and chronic phases of illness.

Discussion

The clinical symptoms of bone and joint infection are not typical and are easily confused with other diseases. The detection rate of conventional imaging modalities for early lesions is low. Microbial culture and tissue biopsy are time-consuming processes. These challenges make the diagnosis more difficult and also reflect the necessity of our research. As far as we know, this study is currently the largest sample size in the diagnostic efficacy of 99mTc-MDP SPECT/CT for bone infections worldwide, and it is also one of the few studies to compare with MRI. More importantly, we also analyzed the impact of metal implants and acute and chronic disease factors, as well as whether combined use with MRI can improve diagnostic efficacy.

SPECT/CT technology can provide more accurate diagnostic results. This technology amalgamates the advantages of SPECT and CT, offering images that concurrently delineate metabolic activity and cross-sectional anatomical structure, allowing for a more accurate assessment of the nature, location, size, and degree of acute and chronic activity of bone-positive lesions (9). According to reports, SPECT/CT can increase the diagnostic specificity from 78% to 89% and maintain 100% high sensitivity compared to SPECT alone (10). Since the 1970s, 99mTc labeled MDP has been widely used as an imaging agent in various orthopedic metabolic diseases in clinical practice (9, 11).

The results of this article indicate that the overall sensitivity, specificity, and diagnostic accuracy of 99mTc-MDP SPECT/CT are significantly superior to MRI, and its diagnostic consistency with the gold standard is also as high as 0.792. This confirms that SPECT/CT has an extremely high diagnostic ability for bone infection compared to conventional imaging examinations. Overall, our conclusion is better than Paez’s diagnostic efficacy for individual items in postoperative vertebral infection, and also better than Lee’s conclusion. Especially in the presence of metallic implants, the diagnostic ability of SPECT/CT is particularly outstanding, with sensitivity and specificity of 95% and 89%, respectively, and consistency of 0.695, which is significantly higher than that of the MRI group (12, 13). However, the total sensitivity and specificity of 99mTc labeled anti-granulocyte SPECT/CT examination on suspected osteomyelitis and implant infection patients by Plate were only 77.8% and 94.1%, respectively (14).

Previously, MRI was recognized for its high sensitivity in detecting early infection, including local edema, exudation, and soft tissue abnormalities (15). However, this also made it easy to misdiagnose, especially metal implants that could introduce artifacts that reduced diagnostic accuracy, making it difficult to differentiate from sterile inflammation (1517). Therefore, relying solely on MRI to evaluate bone infection is limited, especially in patients with metal implants. Our data further indicates that the diagnostic accuracy of MRI in patients with endoprostheses is just 89%, with a consistency of only 0.457 when compared to the gold standard. This significantly trails behind the 96% accuracy and 0.766 consistency of 99mTc-MDP SPECT/CT, aligning with earlier reports (18).

From the perspective of onset time, both 99mTc-MDP SPECT/CT and MRI have good diagnostic capabilities in the early stages of the disease. Based on the patient’s symptoms and signs, the sensitivity and specificity of SPECT/CT diagnosis are as high as 98% and 100%, which are higher than 88% and 89% of MRI. The diagnostic consistency with the gold standard is also as high as 0.897. Compared to the high diagnostic ability in the acute phase, the disappearance of local symptoms in the chronic phase weakens, and the difficulty of imaging judgment increases. The consistency between the two imaging methods and the gold standard diagnosis has decreased, but SPECT/CT still maintains good results, with a Kappa value of up to 0.766. This is because in both acute and chronic stages, the blood flow and bone salt metabolism at the local infection site are higher than others, while edema and inflammatory exudation are not significant. In clinical practice, chronic osteomyelitis only manifests as cortical thickening on MRI. A single sign makes it difficult for radiologists to obtain accurate diagnosis. Therefore, we believe that compared to MRI, SPECT/CT can detect infection in the early stage and provide accurate diagnosis in the chronic stage, providing an accurate basis for the design of antibacterial treatment plans in the later stage. Especially in the presence of metallic implants, the diagnostic accuracy and consistency with the gold standard of SPECT/CT are superior to MRI in both acute and chronic infections.

In addition, the diversity of trauma mechanisms and the complexity of surgical repair in real life can make it difficult to determine the extent of bone infection. The complete debridement range of surgery is one of the important factors affecting postoperative recurrence (19). MRI cannot distinguish whether the high signal area is caused by edema or inflammation on imaging. Filippi et al. reported that 99mTc labeled white blood cell SPECT/CT can accurately delineate the infection range (20); Kim et al. also reported that labeled white blood cell SPECT/CT imaging can accurately locate infectious lesions and delineate the scope of infection (21). Similarly, during the research process, We also found that in addition to its excellent diagnostic performance, SPECT/CT can accurately define the degree of infection by using its radiation count distribution isolines (ISO). This is because the intake of MDP changes with the degree of inflammatory stimulation, presenting a gradual state of central strength and peripheral weakness. We infer that this approach can provide a reliable basis for thorough debridement in clinical practice, thereby avoiding overtreatment and improving the cure rate of chronic hematogenous osteomyelitis.

Furthermore, the overall specificity and sensitivity of patients using a combination of two tests are superior to those using MRI alone, and their diagnostic ability is similar to that of 99mTc-MDP SPECT/CT alone. After conducting a subgroup analysis of whether or not there were metallic implants, it was found that in the absence of metallic implants, patients who underwent both tests had a similar diagnostic ability to the overall population and were close to the parameter results of SPECT/CT alone, as well as significantly superior to MRI detection alone. It is worth noting that in the joint analysis, the results of using MRI alone with corresponding low values once again indicate that it cannot effectively distinguish between real infections and other inflammatory diseases. As shown in our case (Figure 2), the patient had no obvious cause of pain accompanied by local pus discharge. The MRI findings only showed local soft tissue edema, while SPECT/CT showed local bone changes and soft tissue infections. In another case (Figure 3), more than 9 months after the patient underwent open reduction and internal fixation surgery, the pain was found at the right thigh wound, with pus discharge and sinus formation visible. Obvious metal artifacts can be seen in MRI, and local observations can only show obvious edema, while SPECT/CT fusion tomography imaging can clearly show bone changes in the surgical area with abnormal bone metabolism, low-density shadows in soft tissue, and sinus formation, which is in line with infectious changes.

Figure 2
www.frontiersin.org

Figure 2 Male. 43y. There is no obvious cause of right lower limb pain, local swelling with pus discharge, and the pain worsens after activity. No fever. More than 10 years ago, the right femoral shaft fracture underwent reduction and internal fixation surgery and was removed. The physical examination was negative. WBC: 8.37×109/L; LYM%: 16.7%; MONO%: 6.7%; NE%: 74.9%; ESR: 16.0 mm/hr; hs-CRP: 0.69 mg/L. Pathological examination showed infiltration of neutrophils, visible necrosis and abscess formation, and inflammatory changes. (A) SPECT/CT shows bone changes in the right proximal femur and right hip joint area with abnormal bone metabolism, which is consistent with chronic infectious disease. (B) MRI considers bony fusion of the right hip joint; Bone protrusions in the upper and middle segments of the right femur, considering ectopic ossification; Edematous changes in the right soft tissue.

Figure 3
www.frontiersin.org

Figure 3 Male. 61y. After 9 months of open reduction and internal fixation for intertrochanteric fracture of the femur. Pain at the right thigh wound, with purulent discharge visible. A sinus formation can be seen in the middle section of the scar on the left thigh after surgery, with a small amount of secretion oozing out. WBC: 4.79×109/L; LYM%: 32.6%; MONO%: 6.7%; NE%: 54.1%; hs-CRP: 2.11mg/L. Bacterial culture suggests Escherichia coli. (A) SPECT/CT suggests that after the right proximal femur surgery, there are bone changes in the surgical area accompanied by abnormal bone metabolism, as well as low-density soft tissue shadows and sinus formation (yellow arrow), suggesting an infectious lesion. (B) MRI considers changes after internal fixation surgery, resulting in swelling of the thigh soft tissue. Edema of subcutaneous soft tissue on the outer side of the right thigh.

Through the analysis of a large sample size of data, our data can strongly demonstrate that 99mTc-MDP SPECT/CT has great advantages in diagnosing infectious bone diseases and other related aspects compared to MRI. Less impacted by metal implants, 99mTc-MDP SPECT/CT can accurately assess the nature and location of the condition and delineate the infection extent, aiding clinicians in treatment planning and enhancing cure rates. Our data conclusion supports a new diagnostic process, where patients with clinical symptoms pointing to infection and metal implants or in the chronic stage of the disease can implement SPECT/CT as soon as possible. This not only enables timely diagnosis but also reduces the patient’s excessive energy and economic consumption. However, it is undeniable that in clinical practice, MRI can display the adjacent structures around bones, such as the imaging characteristics and anatomical relationships of nerves and blood vessels. Therefore, we believe that adding MRI to the 99mTc-MDP SPECT/CT diagnosis and subsequent treatment is necessary, and this combined approach is helpful for the diagnosis and treatment of patients.

This study also has certain limitations. Firstly, although we use previous experience to comprehensively assess the patient’s condition to include patients, we mainly rely on the judgment of clinical doctors, which may lead to bias. Nonetheless, the accuracy observed in our study aligns with the overall accuracy reported in existing literature. Furthermore, the exclusion of specific infections from our study suggests the possibility of alternative conclusions. Most importantly, this study is retrospective, and there may be various circumstances that affect the conclusion, such as the deviation of the completeness and homogeneity of data collection, and the difficulty in ensuring the consistency of doctors’ examination methods and diagnostic criteria. Further prospective studies should be conducted to verify the results.

Conclusion

In summary, 99mTc-MDP SPECT/CT tomographic fusion imaging is a highly suitable non-invasive diagnostic modality. Especially in the chronic stage of metal implant and infection, its diagnostic ability is more prominent than MRI. Early adoption after a comprehensive assessment of the situation may be more helpful for clinical follow-up treatment.

Ethical approval statement

The institutional review board of the ethics committee at our institution approved this study (No. K202309-12).

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving humans were approved by the Medical Ethics Committee of the Second Affiliated Hospital, Air Force Medical University. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.

Author contributions

HG: Data curation, Investigation, Writing – original draft, Writing – review & editing, Methodology, Project administration, Software, Validation, Visualization. GL: Methodology, Formal analysis, Investigation, Resources, Writing – original draft. CF: Data curation, Investigation, Validation, Writing – original draft, Writing – review & editing. JR: Data curation, Investigation, Writing – original draft, Validation. FK: Resources, Writing – review & editing. WL: Formal analysis, Resources, Writing – review & editing. QY: Formal analysis, Resources, Writing – review & editing. CZ: Formal analysis, Investigation, Writing – review & editing. BL: Formal analysis, Investigation, Writing – review & editing. SL: Validation, Writing – review & editing. HW: Investigation, Writing – review & editing. YFZ: Conceptualization, Methodology, Resources, Supervision, Writing – review & editing, Data curation, Funding acquisition, Project administration, Writing – original draft. YZ: Conceptualization, Methodology, Resources, Supervision, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the School Science and Technology Development Fund Project (2022XC050).

Acknowledgments

We are grateful to all participants and their families enrolled in this study.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Walter N, Baertl S, Alt V, Rupp M. What is the burden of osteomyelitis in Germany? An analysis of inpatient data from 2008 through 2018. BMC Infect Dis (2021) 21(1):550. doi: 10.1186/s12879-021-06274-6

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Kim J, Lee MU, Kim T-H. Nationwide epidemiologic study for pediatric osteomyelitis and septic arthritis in South Korea. Med (Baltimore) (2019) 98(17):e15355. doi: 10.1097/MD.0000000000015355

CrossRef Full Text | Google Scholar

3. Glaudemans AWJM, Jutte PC, Cataldo MA, Cassar-Pullicino V, Gheysens O, Borens O, et al. Consensus document for the diagnosis of peripheral bone infection in adults: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement). Eur J Nucl Med Mol Imaging (2019) 46(4):957–70. doi: 10.1007/s00259-019-4262-x

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Strobel K, Stumpe K. PET/CT in musculoskeletal infection. Semin Musculoskelet Radiol (2007) 11(4):353–64. doi: 10.1055/s-2008-1060337

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Seltzer A, Xiao R, Fernandez M, Hasija R. Role of nuclear medicine imaging in evaluation of orthopedic infections, current concepts. J Clin Orthopaedics Trauma (2019) 10(4):721–32. doi: 10.1016/j.jcot.2019.04.024

CrossRef Full Text | Google Scholar

6. Govaert GAM, Glaudemans AWJM. Nuclear medicine imaging of posttraumatic osteomyelitis. Eur J Trauma Emerg Surg (2016) 42(4):397–410. doi: 10.1007/s00068-016-0647-8

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Depypere M, Morgenstern M, Kuehl R, Senneville E, Moriarty TF, Obremskey WT, et al. Pathogenesis and management of fracture-related infection. Clin Microbiol Infection (2020) 26(5):572–8. doi: 10.1016/j.cmi.2019.08.006

CrossRef Full Text | Google Scholar

8. Tiemann AH, Hofmann GO. Principles of the therapy of bone infections in adult extremities. Strategies Trauma Limb Reconstr (2009) 4(2):57–64. doi: 10.1007/s11751-009-0059-y

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Israel O, Pellet O, Biassoni L, De Palma D, Estrada-Lobato E, Gnanasegaran G, et al. Two decades of SPECT/CT - the coming of age of a technology: An updated review of literature evidence. Eur J Nucl Med Mol Imaging (2019) 46(10):1990–2012. doi: 10.1007/s00259-019-04404-6

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Horger M, Eschmann SM, Pfannenberg C, Storek D, Dammann F, Vonthein R, et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging (2003) 30(12):1665–73. doi: 10.1007/s00259-003-1321-z

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Baqer MM, Loutfi I. Optimal imaging positions for 3-phase bone scanning of patients with bony pathology of the feet. J Nucl Med Technol (2010) 38(2):69–75. doi: 10.2967/jnmt.109.070771

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Paez D, Sathekge MM, Douis H, Giammarile F, Fatima S, Dhal A, et al. Comparison of MRI, [(18)F]FDG PET/CT, and (99m)Tc-UBI 29-41 scintigraphy for postoperative spondylodiscitis-a prospective multicenter study. Eur J Nucl Med Mol Imaging (2021) 48(6):1864–75. doi: 10.1007/s00259-020-05109-x

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Lee SJ, Won KS, Choi HJ, Choi YY. Early-phase SPECT/CT for diagnosing osteomyelitis: A retrospective pilot study. Korean J Radiol (2021) 22(4):604. doi: 10.3348/kjr.2019.0746

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Plate A, Weichselbaumer V, Schüpbach R, Fucentese SF, Berli M, Hüllner M, et al. Diagnostic accuracy of (99m)Tc-antigranulocyte SPECT/CT in patients with osteomyelitis and orthopaedic device-related infections: A retrospective analysis. Int J Infect Diseases (2020) 91:79–86. doi: 10.1016/j.ijid.2019.11.017

CrossRef Full Text | Google Scholar

15. Bhure U, Agten C, Lehnick D, Perez-Lago MDS, Beeres F, Link B-C, et al. Value of SPECT/CT in the assessment of necrotic bone fragments in patients with delayed bone healing or non-union after traumatic fractures. Br J Radiol (2020) 93(1114):20200300. doi: 10.1259/bjr.20200300

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Glaudemans A, Galli F, Pacilio M, Signore A. Leukocyte and bacteria imaging in prosthetic joint infection. eCM (2013) 25:61–77. doi: 10.22203/ecm.v025a05

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Yang J, Yao J-L, Wu Z-Q, Zeng D-L, Zheng L-Y, Chen D, et al. Current opinions on the mechanism, classification, imaging diagnosis and treatment of post-traumatic osteomyelitis. Chin J Traumatol (2021) 24(6):320–7. doi: 10.1016/j.cjtee.2021.07.006

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Ledermann HP, Kaim A, Bongartz G, Steinbrich W. Pitfalls and limitations of magnetic resonance imaging in chronic posttraumatic osteomyelitis. Eur Radiol (2000) 10(11):1815–23. doi: 10.1007/s003300000480

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Tice AD, Hoaglund PA, Shoultz DA. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am J Med (2003) 114(9):723–8. doi: 10.1016/s0002-9343(03)00231-6

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Filippi L, Uccioli L, Giurato L, Schillaci O. Diabetic foot infection: usefulness of SPECT/CT for 99mTc-HMPAO-labeled leukocyte imaging. J Nucl Med (2009) 50(7):1042–6. doi: 10.2967/jnumed.108.059493

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Kim HO, Na SJ, Oh SJ, Jung BS, Lee S-H, Chang JS, et al. Usefulness of adding SPECT/CT to 99mTc-hexamethylpropylene amine oxime (HMPAO)-labeled leukocyte imaging for diagnosing prosthetic joint infections. J Comput Assist Tomogr (2014) 38(2):313–9. doi: 10.1097/RCT.0000000000000011

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: 99mTc-MDP SPECT/CT, MRI, diagnostic efficacy, bone and joint infections, osteomyelitis

Citation: Gao H, Li G, Fu C, Ren J, Kang F, Luo W, Yin Q, Zhou C, Li B, Lu S, Wang H, Zhang Y and Zhang Y (2024) Comparison of diagnostic efficacy between 99mTc-methylene diphosphate SPECT/CT and MRI for bone and joint infections: a multicenter retrospective analysis. Front. Endocrinol. 15:1359655. doi: 10.3389/fendo.2024.1359655

Received: 21 December 2023; Accepted: 18 January 2024;
Published: 29 February 2024.

Edited by:

Wu Zhou, Huazhong University of Science and Technology, China

Reviewed by:

Yanxi Chen, Fudan University, China
Bobin Mi, Huazhong University of Science and Technology, China

Copyright © 2024 Gao, Li, Fu, Ren, Kang, Luo, Yin, Zhou, Li, Lu, Wang, Zhang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yunfei Zhang, tdbone@163.com; Yong Zhang, tdgk09@163.com

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.